BioNTech SE (BNTX) Financials

BNTX Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 24.0 billion 2.5 billion
2023-12-31 25.4 billion 3.1 billion
2023-09-30 23.5 billion 2.5 billion
2023-06-30 24.2 billion 2.5 billion

BNTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -490.2 million 17.6 million
2023-12-31 730.4 million 15.7 million
2023-09-30 698.7 million 16.4 million
2023-06-30 4.4 billion 14.2 million

BNTX Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 -358.1 million
2023-12-31 733.1 million
2023-09-30 240.7 million
2023-06-30 -448.2 million

BNTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 16.9 billion - -
2023-12-31 18.3 billion - -
2023-09-30 16.7 billion - -
2023-06-30 16.9 billion - -

BNTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 259.6 million
2023-12-31 267.4 million
2023-09-30 253.8 million
2023-06-30 260.7 million

BNTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 147.7 million 547.7 million 126.3 million 16.8 million
2023-12-31 210.3 million 638.7 million 145.3 million 19.9 million
2023-09-30 160.1 million 542.4 million 144.4 million 15.2 million
2023-06-30 336.3 million 405.1 million 133.4 million 19.7 million

BNTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 202.5 million 63.8 million
2023-12-31 1.6 billion 198.0 million
2023-09-30 947.8 million 698.4 million
2023-06-30 182.3 million 583.1 million

BNTX

Price: $91.80

52 week price:
85.21
125.83

Earnings Per Share: 4.11 USD

P/E Ratio: 7.68

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 379200

Market Capitalization: 22.1 billion

Links: